Cabozantinib (C) exposure-response (ER) modeling of efficacy and safety endpoints as a function of clearance in patients (pts) with renal cell carcinoma (RCC) Meeting Abstract
| Authors: | Jonasch, E.; Motzer, R. J.; Escudier, B.; Powles, T.; Markby, D. W.; Nielsen, J.; Lacy, S.; Choueiri, T. K. |
| Abstract Title: | Cabozantinib (C) exposure-response (ER) modeling of efficacy and safety endpoints as a function of clearance in patients (pts) with renal cell carcinoma (RCC) |
| Meeting Title: | 2018 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2018 Feb 8-10 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-02-20 |
| Language: | English |
| ACCESSION: | WOS:000436179500639 |
| DOI: | 10.1200/JCO.2018.36.6_suppl.645 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 645 -- Source: Wos |
